121 related articles for article (PubMed ID: 9561247)
1. X-ray crystallographic studies of the complex between porcine pepsin and the aspartic proteinase inhibitor PI-3 from the nematode Ascaris suum.
Petersen JF; Chernaia MM; Rao-Naik C; Zalatoris JL; Dunn BM; James MN
Adv Exp Med Biol; 1998; 436():391-5. PubMed ID: 9561247
[No Abstract] [Full Text] [Related]
2. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
[TBL] [Abstract][Full Text] [Related]
3. The disulphide bond arrangement in the major pepsin inhibitor PI-3 of Ascaris suum.
Girdwood K; Berry C
FEBS Lett; 2000 Jun; 474(2-3):253-4. PubMed ID: 10896483
[No Abstract] [Full Text] [Related]
4. Expression, purification, and characterization of the recombinant pepsin inhibitor from Ascaris suum.
Zalatoris J; Rao-Naik C; Fecho G; Girdwood K; Kay J; Dunn BM
Adv Exp Med Biol; 1998; 436():387-9. PubMed ID: 9561246
[No Abstract] [Full Text] [Related]
5. Aspartic protease inhibitors from the parasitic nematode Ascaris.
Martzen MR; McMullen BA; Fujikawa K; Peanasky RJ
Adv Exp Med Biol; 1991; 306():63-73. PubMed ID: 1812760
[No Abstract] [Full Text] [Related]
6. Design and synthesis of unsymmetrical peptidyl urea inhibitors of aspartic peptidases.
Dales NA; Bohacek RS; Satyshur KA; Rich DH
Org Lett; 2001 Jul; 3(15):2313-6. PubMed ID: 11463304
[TBL] [Abstract][Full Text] [Related]
7. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
Andreeva NS; Bochkarev A; Pechik I
Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
[No Abstract] [Full Text] [Related]
8. An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases.
Bailey D; Carpenter EP; Coker A; Coker S; Read J; Jones AT; Erskine P; Aguilar CF; Badasso M; Toldo L; Rippmann F; Sanz-Aparicio J; Albert A; Blundell TL; Roberts NB; Wood SP; Cooper JB
Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):541-52. PubMed ID: 22525752
[TBL] [Abstract][Full Text] [Related]
9. Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteases.
Moose RE; Clemente JC; Jackson LR; Ngo M; Wooten K; Chang R; Bennett A; Chakraborty S; Yowell CA; Dame JB; Agbandje-McKenna M; Dunn BM
Biochemistry; 2007 Dec; 46(49):14198-205. PubMed ID: 18004881
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
Kuzmic P; Sun CQ; Zhao ZC; Rich DH
Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
[No Abstract] [Full Text] [Related]
11. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E.
Kageyama T
Eur J Biochem; 1998 May; 253(3):804-9. PubMed ID: 9654082
[TBL] [Abstract][Full Text] [Related]
12. From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases.
Bursavich MG; West CW; Rich DH
Org Lett; 2001 Jul; 3(15):2317-20. PubMed ID: 11463305
[TBL] [Abstract][Full Text] [Related]
13. A new type of aspartic proteinase inhibitors with a symmetric structure.
Tarasova NI; Gulnik SV; Prischenko AA; Livantsov MV; Lysogorskaya EN; Oksenoit ES
Adv Exp Med Biol; 1991; 306():539-42. PubMed ID: 1812755
[No Abstract] [Full Text] [Related]
14. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
15. Conformation analysis of non-pepsin-type acid proteinase A from the fungus Aspergillus niger by NMR.
Kojima M; Tanokura M; Muto Y; Miyano H; Suzuki E; Hamaya T; Takizawa T; Kono T; Takahashi K
Adv Exp Med Biol; 1995; 362():611-5. PubMed ID: 8540381
[No Abstract] [Full Text] [Related]
16. X-ray crystallographic study of a non-pepsin-type acid proteinase, Aspergillus niger proteinase A.
Sasaki H; Tanokura M; Muramatsu T; Nakagawa A; Iwata S; Hamaya T; Takizawa T; Kono T; Takahashi K
Adv Exp Med Biol; 1995; 362():605-9. PubMed ID: 8540380
[No Abstract] [Full Text] [Related]
17. Overcoming the unfavourable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin.
Fraser ME; Meyer JH; Bartlett PA; James MN
Adv Exp Med Biol; 1998; 436():355-9. PubMed ID: 9561242
[No Abstract] [Full Text] [Related]
18. Aspartic protease inhibitors designed from computer-generated templates bind as predicted.
Ripka AS; Satyshur KA; Bohacek RS; Rich DH
Org Lett; 2001 Jul; 3(15):2309-12. PubMed ID: 11463303
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn.
Winterburn TJ; Wyatt DM; Phylip LH; Berry C; Bur D; Kay J
Biol Chem; 2006 Aug; 387(8):1139-42. PubMed ID: 16895485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
